Keyword: diabetes treatment
News
09.09.2022
-
Denmark’s Novo Nordisk has entered into a global license and development with compatriot biotech Zealand Pharma for the latter’s Zegalogue (dasiglucagon) injectable...
News
13.08.2014
- Sanofi and MannKind Corporation have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a...
News
02.06.2014
- Danish drugmaker Novo Nordisk, the world's biggest insulin producer, has decided to launch its diabetes drug Tresiba in Germany after seeing signs of a more favorable pricing...
News
09.04.2014
- Japanese drug giant Takeda Pharmaceutical has vowed to fight a $6 billion damages award to U.S. plaintiffs who blamed its Actos diabetes drug for their bladder cancer. The company...
News
31.03.2014
- Bayer HealthCare plans to spend around €100 million to "significantly increase" capacity of its Beijing, China pharmaceutical packaging facilities, the Leverkusen-based group said...
News
21.03.2014
- Novo Nordisk should still be able to introduce its long-acting insulin Tresiba on the U.S. market before rival products, despite being hit by a delay, the CEO of the Danish...
News
04.03.2014
- Scientists have uncovered gene mutations that slash the risk of Type 2 diabetes regardless of age and weight, offering drugmakers a novel target to combat one of the major health...
News
20.09.2013
- Swiss drugmaker Roche has decided against trying to sell its blood glucose meter business, according to two people familiar with the matter. In the past few months, Roche was...
